Name: PHAXIAM Therapeutics S.A. Rightofuse Assets 2018-2023
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

PHAXIAM Therapeutics S.A. Rightofuse Assets

PHAXIAM Therapeutics S.A. had Rightofuse Assets of EUR 2.94 million as of 2023-06-30, per its 6-K filed 2023-09-26.

Discontinued › Notes

ifrs-full:RightofuseAssets · last filed 2023-09-26

2023-06-30: Rightofuse Assets 2.94M EUR.
2022-12-31: Rightofuse Assets 2.58M EUR.
2020-12-31: Rightofuse Assets 8.23M EUR.
2020-06-30: Rightofuse Assets 9.27M EUR.

Period end	Rightofuse Assets
2023-06-30	2.94M EUR 6-K · filed 2023-09-26
2022-12-31	2.58M EUR 6-K · filed 2023-09-26
2020-12-31	8.23M EUR 20-F · filed 2021-03-08
2020-06-30	9.27M EUR 6-K · filed 2020-09-21
2019-12-31	10.01M EUR 20-F · filed 2021-03-08
2019-06-30	6.63M EUR 6-K · filed 2019-09-26
2018-12-31	0.00 EUR 20-F · filed 2021-03-08